Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Meiogenix is a biotechnology company that develops breeding technologies.
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.
Accipiter Biosciences is a biotechnology company.
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
CIBO scales regenerative advanced platform technology that connects growers to incentives and enterprises to growers.
Recludix pharma is a developing platform to treat cancer patients.
Eclipse Bioinnovations is an RNA genomics company that provides products and services to academic and industry customers around the world.
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .
Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.
Halio is developing adaptive, dynamic glass for the commercial, residential, and automotive markets.
Haystack Oncology enables precision oncology to optimize treatment strategies.
NILO Therapeutics is a biotechnology and therapeutics company.
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.
Immunai is a biotech company that provides mapping and reprogramming immunology, machine learning, and software engineering.
Industrial-scale genome sequencing
Crop Enhancement develop sustainable agrochemical formulations that employ environmentally friendly chemistry to improve crop yields.
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
Invaio Sciences is a technology company that is dedicated to solving pressing agriculture, nutrition, and environmental challenges.
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
CrossBridge Bio operates as a biotechnology company.
Tr1x is a biotechnology company developing novel cellular immunotherapies for patients with autoimmune and inflammatory diseases.
Alexandria Venture Investments has invested in 186 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Alexandria Venture Investments's top investment sectors include Biotechnology, Therapeutics, Life Science, Health Care, Medical. The firm invests across 35 different industry categories.
Among tracked funding rounds, Immunai received $215.0M in a Series B round. Alexandria Venture Investments's total known invested capital is $7.4B.
Alexandria Venture Investments's average investment size is $50.9M across its portfolio of 186 companies.
Recent Alexandria Venture Investments portfolio additions include Meiogenix, TwoStep Therapeutics, Variant Bio, Accipiter Biosciences, Parthenon Therapeutics. These companies were founded in 2020 or later.